New FDA guidance for pharma on "countering misinformation" online
FDA authorizes pharmas to lie when needed, promising non-enforcement of pharmaceutical marketing regs. I interpret this as we are winning the information war.
Endpoint News:
The FDA on Monday laid out its latest expectations for how pharma companies can correct misinformation spreading online about their medical products.
The draft guidance, which comes in the form of a Q&A and reworks a similar version from 2014, is the latest in a series of FDA efforts to combat misinformation more broadly, which FDA Commissi…
Keep reading with a 7-day free trial
Subscribe to Due Diligence and Art to keep reading this post and get 7 days of free access to the full post archives.